Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 413

Results For "MS"

5470 News Found

North India’s first biotech park at Kathua, J&K inaugurated
News | May 30, 2022

North India’s first biotech park at Kathua, J&K inaugurated

Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas


All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022
Healthcare | May 29, 2022

All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022

The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds


USFDA approves two Opdivo-based regimens
Biotech | May 29, 2022

USFDA approves two Opdivo-based regimens

Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers


JBCL rebrands as JB
News | May 29, 2022

JBCL rebrands as JB

JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India


Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania
News | May 27, 2022

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania

The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential


Torrent Pharma acquires four brands from Dr Reddy’s
News | May 27, 2022

Torrent Pharma acquires four brands from Dr Reddy’s

The integration and transition of the brands are expected to be completed by June 2022.


Next-gen immunotherapy drug shows promise in several advanced-stage cancers
Biotech | May 27, 2022

Next-gen immunotherapy drug shows promise in several advanced-stage cancers

Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells


CorePath partners with Cizzle Bio to develop blood test to detect lung cancer
Biotech | May 27, 2022

CorePath partners with Cizzle Bio to develop blood test to detect lung cancer

Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths


Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis
Biotech | May 27, 2022

Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis

Data from the three studies formed the basis of the company's application for approval by regulatory agencies


DFE Pharma opens its new Center of Excellence in Hyderabad, India
News | May 27, 2022

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs